Related Experiment Video
Updated: May 30, 2025

08:01
Design of an Open-Source, Low-Cost Bioink and Food Melt Extrusion 3D Printer
Published on: March 2, 2020
9.8K
Enhancing Patient-Centric Drug Development: Coupling Hot Melt Extrusion with Fused Deposition Modeling and
Dinesh Nyavanandi1, Preethi Mandati2, Nithin Vidiyala1
1Small Molecule Drug Product Development, Cerevel Therapeutics, Cambridge, MA 02141, USA.
Pharmaceutics
|January 25, 2025
Summary
Additive manufacturing offers solutions for patient-centric medications, moving beyond traditional methods. Nozzle-based techniques like pressure-assisted microsyringe (PAM) and fused deposition modeling (FDM) enable complex drug formulations for personalized medicine.
Area of Science:
- Pharmaceutical Manufacturing
- Materials Science
- Drug Delivery Systems
Background:
- Traditional pharmaceutical manufacturing struggles to meet the growing demand for complex, patient-centric medications.
- Existing methods like direct blending and granulation are inadequate for personalized dosing, combinations, and release profiles.
- The "one size fits all" approach in medicine is increasingly being replaced by a need for tailored treatments.
Purpose of the Study:
- To review advancements in additive manufacturing for creating patient-centric medications.
- To explore nozzle-based additive manufacturing techniques, specifically pressure-assisted microsyringe (PAM) and fused deposition modeling (FDM).
- To discuss the integration of these techniques with hot melt extrusion (HME) for continuous manufacturing and quality control.
Main Methods:
- Review of literature on nozzle-based additive manufacturing (PAM, FDM) for pharmaceutical applications.
- Discussion of thermal energy application in these processes and PAM's ambient condition capability.
- Exploration of pairing nozzle-based techniques with hot melt extrusion (HME) for continuous manufacturing.
Main Results:
- Nozzle-based additive manufacturing platforms (PAM, FDM) show significant potential for developing complex and on-demand medications.
- These techniques can be integrated with hot melt extrusion (HME) and process analytical technology (PAT) for continuous manufacturing.
- Critical parameters influencing product quality, continuous manufacturing, quality by design (QbD), and future perspectives are discussed.
Conclusions:
- Additive manufacturing, particularly nozzle-based methods, is crucial for advancing patient-centric pharmaceutical development.
- Integration with HME and PAT enables robust continuous manufacturing processes for safe and effective medications.
- Further research into critical parameters and QbD is essential for realizing the full potential of these technologies.

